Articles related to DRUG SAFETY & INTERACTIONS

Medication-induced ocular complications can occur across multiple drug classes, with risk factors including dosage, duration of treatment, and individual patient susceptibility.

Anticholinergic medications require careful consideration of both peripheral and central effects, particularly in patients with existing cognitive impairments.

The expansion of this recall highlights the critical importance of verifying medication packaging against blister strip labeling, particularly for controlled substances where precise dosing is essential.

Laboratory analysis reveals montelukast demonstrates “significant binding” to multiple brain receptors, suggesting more extensive neurological activity than previously understood.

23 million Americans take levothyroxine daily, making it one of the nation’s most prescribed medications, with new evidence suggesting potential risks to bone health even at standard therapeutic levels.

Adverse events from compounded semaglutide have led to hundreds of hospitalizations, highlighting critical safety concerns for healthcare providers managing patients seeking weight loss solutions.